Page last updated: 2024-08-23

daunorubicin and Thymoma

daunorubicin has been researched along with Thymoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourgeois, S; Gruol, DJ; Trotter, J; Zee, MC1
Hama-Inaba, H; Matsushima, T; Mori, M; Muto, M; Ohyama, H; Saitoh, T; Takusagawa, M; Wang, B; Yamada, T1
Mihich, E; Orsini, F; Pavelic, Z1
Ujiie, T1
McKenzie, IF; Pietersz, GA; Smyth, MJ2

Other Studies

6 other study(ies) available for daunorubicin and Thymoma

ArticleYear
Reversal of multidrug resistance by RU 486.
    Cancer research, 1994, Jun-15, Volume: 54, Issue:12

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Colchicine; Daunorubicin; Dexamethasone; Drug Resistance; Female; Kinetics; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mifepristone; Phenotype; Puromycin; Structure-Activity Relationship; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Verapamil

1994
Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation.
    Mutation research, 1998, Jul-17, Volume: 403, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Daunorubicin; Drug Resistance; Genetic Variation; Methyl Methanesulfonate; Mice; Mitomycin; Mutagens; Radiation Tolerance; Sphingosine; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1998
Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
    Cancer research, 1977, Volume: 37, Issue:6

    Topics: Animals; Antigens, Neoplasm; Cell Adhesion; Cell Separation; Cells, Cultured; Cytotoxicity Tests, Immunologic; Daunorubicin; Doxorubicin; Epitopes; Immunity, Cellular; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Macrophages; Mast-Cell Sarcoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Spleen; Thymoma; Time Factors

1977
Immunogenic potential of tumor cells after treatment with antitumor chemotherapeutic agents.
    The Japanese journal of experimental medicine, 1988, Volume: 58, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Cyclophosphamide; Cytotoxicity, Immunologic; Daunorubicin; Doxorubicin; Female; Immunity, Innate; Immunization; Mice; Mice, Inbred C57BL; Mitomycin; Mitomycins; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Spleen; Thymoma; Tumor Cells, Cultured

1988
Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates.
    Journal of the National Cancer Institute, 1987, Volume: 79, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Antibodies, Monoclonal; Cell Division; Cyclandelate; Daunorubicin; DNA Replication; Idarubicin; Mandelic Acids; Mice; Mice, Inbred Strains; Perfusion; Prazosin; Thymoma; Thymus Neoplasms

1987
Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
    Cancer research, 1988, Feb-15, Volume: 48, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Cell Division; Cell Line; Cell Survival; Daunorubicin; Humans; Idarubicin; Immunotherapy; Mice; Mice, Inbred Strains; Thymoma; Thymus Neoplasms

1988